Literature DB >> 12402207

Gastric Helicobacter species infection in murine and gerbil models: comparative analysis of effects of H. pylori and H. felis on gastric epithelial cell proliferation.

Michelle Court1, Philip A Robinson, Michael F Dixon, Jean E Crabtree.   

Abstract

C57BL/6 mice and Mongolian gerbils were infected with Helicobacter felis and Helicobacter pylori SS1 strain to investigate the effects of different Helicobacter species on gastric inflammation and epithelial cell proliferation in different animal models. At 4 weeks, gerbils infected with H. pylori or H. felis developed antral gastritis. Onset of gastritis varied between the models, with mice infected with H. pylori having minimal inflammation at 8 weeks. In mice, H. felis, but not H. pylori, induced significantly increased epithelial cell proliferation in the cardia and corpus at 8 weeks, but no changes were observed at 4 weeks. In gerbils, both H. pylori and H. felis significantly increased antral epithelial cell proliferation at 4 weeks. Epithelial cell proliferation induced by H. felis in gerbils was twice that stimulated by H. pylori. These studies demonstrate host differences in the development of Helicobacter species-induced gastric inflammation and a marked difference in epithelial cell proliferation induced by H. pylori and H. felis in 2 animal models.

Entities:  

Mesh:

Year:  2002        PMID: 12402207     DOI: 10.1086/344321

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  10 in total

1.  N-acetylcysteine, a novel treatment for Helicobacter pylori infection.

Authors:  Hien Quoc Huynh; Richard T L Couper; Cuong D Tran; Lynette Moore; Richard Kelso; Ross N Butler
Journal:  Dig Dis Sci       Date:  2004 Nov-Dec       Impact factor: 3.199

Review 2.  Pathogenesis of Helicobacter pylori infection.

Authors:  Johannes G Kusters; Arnoud H M van Vliet; Ernst J Kuipers
Journal:  Clin Microbiol Rev       Date:  2006-07       Impact factor: 26.132

3.  Helicobacter pylori infection of human and murine primary gastric cells.

Authors:  Marguerite Clyne; Brendan Drumm
Journal:  Infect Immun       Date:  2004-09       Impact factor: 3.441

4.  Treatment of Helicobacter gastritis with IL-4 requires somatostatin.

Authors:  Yana Zavros; Sivaprakash Rathinavelu; John Y Kao; Andrea Todisco; John Del Valle; Joel V Weinstock; Malcolm J Low; Juanita L Merchant
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-10       Impact factor: 11.205

5.  Gastric Helicobacter infection inhibits development of oral tolerance to food antigens in mice.

Authors:  Tamara Matysiak-Budnik; Guillaume van Niel; Francis Mégraud; Kathryn Mayo; Claudia Bevilacqua; Valérie Gaboriau-Routhiau; Marie-Christiane Moreau; Martine Heyman
Journal:  Infect Immun       Date:  2003-09       Impact factor: 3.441

6.  Dietary factors modulate Helicobacter-associated gastric cancer in rodent models.

Authors:  James G Fox; Timothy C Wang
Journal:  Toxicol Pathol       Date:  2013-12-03       Impact factor: 1.902

7.  Hepatocyte growth factor regulates the development of highly pure cultured chief cells from rat stomach by stimulating chief cell proliferation in vitro.

Authors:  Kimihito Tashima; Songhua Zhang; Regina Ragasa; Eiji Nakamura; Ji Hye Seo; Asli Muvaffak; Susan J Hagen
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2008-11-20       Impact factor: 4.052

8.  Effects of EGFR Inhibitor on Helicobacter pylori Induced Gastric Epithelial Pathology in Vivo.

Authors:  Jean E Crabtree; Anthony H T Jeremy; Cedric Duval; Michael F Dixon; Kazuma Danjo; Ian M Carr; D Mark Pritchard; Philip A Robinson
Journal:  Pathogens       Date:  2013-10-14

Review 9.  Helicobacter pylori-induced gastric pathology: insights from in vivo and ex vivo models.

Authors:  Michael D Burkitt; Carrie A Duckworth; Jonathan M Williams; D Mark Pritchard
Journal:  Dis Model Mech       Date:  2017-02-01       Impact factor: 5.758

10.  Gastric Helicobacter infection induces iron deficiency in the INS-GAS mouse.

Authors:  Melanie J Thomson; D Mark Pritchard; Sally A Boxall; Abdul A Abuderman; Jonathan M Williams; Andrea Varro; Jean E Crabtree
Journal:  PLoS One       Date:  2012-11-19       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.